NetworkNewsBreaks – BriaCell Therapeutics Corp (OTC: BCTXF) (TSX.V: BCT) Advancing Development of Bria-IMT™ as Immunotherapy Solution for Advanced Breast Cancer Patients
BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, is advancing the development of its lead product candidate Bria-IMT™, which has demonstrated positive results in three clinical studies to date. An article discussing the company reads, “Bria-IMT™ works by providing breast cancer antigens and a direct stimulation of the cancer fighting T-cells. This way, the therapy strengthens the body’s ability to fight cancer. Bria-IMT™ has achieved proof of concept in clinical trials, and its safety has also been assessed as excellent. Even in heavily pre-treated advanced breast cancer patients, Bria-IMT™ managed to elicit tumor…







